e-learning
resources
London 2016
Wednesday, 07.09.2016
Molecular immunology of the lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Impact of demographics and comorbidities on periostin and eosinophil levels
Cecile Holweg (South San Francisco, United States of America), Jochen Brumm, Carol Chung, Akiko Chai, Evan Tan, Irene Braithwaite, Richard Beasley, Julie Olsson, John Matthews, Cecile Holweg
Source:
International Congress 2016 – Molecular immunology of the lung
Session:
Molecular immunology of the lung
Session type:
Oral Presentation
Number:
4950
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Cecile Holweg (South San Francisco, United States of America), Jochen Brumm, Carol Chung, Akiko Chai, Evan Tan, Irene Braithwaite, Richard Beasley, Julie Olsson, John Matthews, Cecile Holweg. LATE-BREAKING ABSTRACT: Impact of demographics and comorbidities on periostin and eosinophil levels. Eur Respir J 2016; 48: Suppl. 60, 4950
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
LATE-BREAKING ABSTRACT: Anti-interleukin-5 in severe asthma: Blood eosinophilia predicts lung function improvement
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013
LATE-BREAKING ABSTRACT: Surfactant protein D is dysregulated in severe asthma
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014
LATE-BREAKING ABSTRACT: Serum periostin as a valuable biomarker of comorbid chronic rhinosinusitis in patients with asthma
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016
LATE-BREAKING ABSTRACT: Why asthma still kills National Review of Asthma Deaths (NRAD)
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014
LATE-BREAKING ABSTRACT: The effect of temperature during sputum processing on inflammatory markers
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Study of psychiatric comorbidities in patients with bronchial asthma
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
LATE-BREAKING ABSTRACT: Using eosinophilic phenotype to characterize asthma control.
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
LATE-BREAKING ABSTRACT: Risk factors of difficult-to-control adult-onset asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
LATE-BREAKING ABSTRACT: The study of fibulin-1 as a novel biomarker in bronchial asthma and its association to disease severity
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
Evaluation of inflammatory markers IL-6 and MMP-9 in asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
LATE-BREAKING ABSTRACT: Reslizumab in patients with late-onset asthma with elevated blood eosinophils
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015
Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
LATE-BREAKING ABSTRACT: Clinical and Epidemiological Characteristics of Hospitalized COPD Exacerbations.
Source: International Congress 2014 – Predictors
Year: 2014
LATE-BREAKING ABSTRACT: The analysis of the severe asthma prevalence rate in China
Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing
Year: 2016
LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
LATE-BREAKING ABSTRACT: Serum IL-13 is a peripheral biomarker for Type 2 asthma
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
LATE-BREAKING ABSTRACT: Oral corticosteroid-sparing effect of mepolizumab in severe eosinophilic asthma: the SIRIUS study
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014
Aspects of the placenta status in women with asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Elevated blood eosinophil is a risk factor for future exacerbations in asthmatic children
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
LATE-BREAKING ABSTRACT: Stability of blood eosinophil count in COPD patients in the UK clinical practice research datalink
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept